Solid Biosciences Inc.: insider trading
254 trades by 33 directors, officers and 10% owners since 2018, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$2.7 M
28 sales by 7 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$25 K
1 sale
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (33)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Gabriel BrooksChief Medical Officer | 97,241 | — | $288 K | |
| Ian F. SmithDirector | 141,585 | — | — | |
| Alexander CumboPresident and CEO, Director | 235,405 | — | $984 K | |
| David T. HowtonChief Operating Officer | 105,077 | — | $434 K | |
| Ilan GanotDirector | 99,297 | — | $69 K | |
| Jessie HanrahanChief Regulatory Officer | 74,318 | — | $297 K | |
| Kevin TanCFO & Treasurer | 99,422 | — | $330 K | |
| Paul HerzichChief Technology Officer | 72,638 | — | $274 K | |
| Clare KahnDirector | 2,960 | — | — | |
| BCLS SB Investco, LP10% owner | — | — | — | |
| Joseph EdelmanDirector, 10% owner | — | — | — | |
| Robert Atchinson10% owner | — | — | — | |
| Adam KoppelDirector, 10% owner | — | — | — | |
| Perceptive Xontogeny Venture Fund, LPDirector, 10% owner | — | — | — | |
| RA Capital Nexus Fund, L.P.Director, 10% owner | — | — | — | |
| Jennifer MarloweCSO | 6,998 | — | — | |
| Carl Ashley MorrisChief Scientific Officer | 19,760 | — | — | |
| Ra Capital Management, L.P.Director, 10% owner | — | — | — | |
| Schneider Joel Solomon ZevChief Operating Officer | 236,270 | — | — | |
| RA Capital Healthcare Fund LPDirector, 10% owner | — | — | — | |
| Peter KolchinskyDirector, 10% owner | — | — | — | |
| Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy | 335,636 | — | — | |
| Matthew Bennett ArnoldDirector | 3.93 M | — | — | |
| Rajeev M. ShahDirector, 10% owner | — | — | — | |
| Lynette HerschaChief Legal Officer | 160,859 | — | — | |
| Martin I. FreedDirector | 53,763 | — | — | |
| Perceptive Advisors LLCDirector, 10% owner | — | — | — | |
| Sukumar NagendranDirector | 34,258 | — | — | |
| Juan Andrey ZarurDirector | 691,105 | — | — | |
| Boxer Capital, LLC10% owner | 3.47 M | — | — | |
| Pedro Alvaro AmorrortuChief Operating Officer | 153,746 | — | — | |
| Jorge Armando QuirozChief Medical Officer | 228,092 | — | — | |
| Gilad David Hayeem10% owner | 1.95 M | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Gabriel BrooksChief Medical Officer | Sell10b5-1 plan | -4,374 | $5.620 | $25 K | 97,241 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Option exercise10b5-1 plan | +9,750 | — | — | 101,615 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +3,440 | — | — | 141,585 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +3,440 | — | — | 138,145 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +3,441 | — | — | 134,705 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Sell10b5-1 plan | -5,404 | $5.820 | $31 K | 99,422 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Sell10b5-1 plan | -0 | $5.820 | $0 | 89,466 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Sell10b5-1 plan | -4,134 | $5.820 | $24 K | 74,318 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Sell10b5-1 plan | -7,469 | $5.820 | $43 K | 105,077 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Sell10b5-1 plan | -3,616 | $5.820 | $21 K | 72,638 | Form 4 |
| filed | Ilan GanotDirector | Sell10b5-1 plan · indirect | -2,658 | $5.820 | $15 K | 27,474 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Sell10b5-1 plan | -16,644 | $5.820 | $97 K | 235,405 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Option exercise10b5-1 plan | +10,625 | — | — | 104,826 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Option exercise10b5-1 plan | +10,937 | — | — | 95,029 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Option exercise10b5-1 plan | +8,125 | — | — | 78,452 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Option exercise10b5-1 plan | +14,687 | — | — | 112,546 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Option exercise10b5-1 plan | +7,187 | — | — | 76,254 | Form 4 |
| filed | Ilan GanotDirector | Option exercise10b5-1 plan · indirect | +4,861 | — | — | 30,132 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Option exercise10b5-1 plan | +30,031 | — | — | 252,049 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Sell10b5-1 plan | -12,348 | $6.440 | $80 K | 70,327 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Sell10b5-1 plan | -18,894 | $6.440 | $122 K | 97,859 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Sell10b5-1 plan | -10,905 | $6.440 | $70 K | 69,067 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Sell10b5-1 plan | -14,783 | $6.440 | $95 K | 94,201 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Sell10b5-1 plan | -48,913 | $6.440 | $315 K | 222,018 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Sell10b5-1 plan | -12,616 | $6.440 | $81 K | 84,092 | Form 4 |
| filed | Ilan GanotDirector | Sell10b5-1 plan · indirect | -7,205 | $6.440 | $46 K | 25,271 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Sell10b5-1 plan | -26,250 | $6.440 | $169 K | 79,972 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Sell10b5-1 plan | -80,258 | $6.440 | $517 K | 270,931 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Sell10b5-1 plan | -28,335 | $6.440 | $182 K | 96,708 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Sell10b5-1 plan | -26,535 | $6.440 | $171 K | 82,675 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Sell10b5-1 plan | -26,837 | $6.440 | $173 K | 108,984 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Sell10b5-1 plan | -37,771 | $6.440 | $243 K | 116,753 | Form 4 |
| filed | Ilan GanotDirector | Option exercise10b5-1 plan · indirect | +15,000 | — | — | 32,476 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Option exercise10b5-1 plan | +24,675 | — | — | 106,222 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Option exercise10b5-1 plan | +28,225 | — | — | 125,043 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Option exercise10b5-1 plan | +100,400 | — | — | 351,189 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Option exercise10b5-1 plan | +33,075 | — | — | 135,821 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Option exercise10b5-1 plan | +42,275 | — | — | 154,254 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Option exercise10b5-1 plan | +27,625 | — | — | 109,210 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Option exercise10b5-1 plan | +169,401 | — | — | 250,789 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Option exercise10b5-1 plan | +54,925 | — | — | 81,547 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Option exercise10b5-1 plan | +58,847 | — | — | 96,818 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Option exercise10b5-1 plan | +54,925 | — | — | 81,585 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Option exercise10b5-1 plan | +56,646 | — | — | 102,746 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Option exercise10b5-1 plan | +79,341 | — | — | 112,249 | Form 4 |
| filed | Ilan GanotDirector | Sell10b5-1 plan · indirect | -191 | $6.590 | $1 K | 17,476 | Form 4 |
| filed | Ilan GanotDirector | Option exercise10b5-1 plan · indirect | +389 | — | — | 17,667 | Form 4 |
| filed | Ilan GanotDirector | Option exercise10b5-1 plan | +3,884 | — | — | 99,297 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Sell10b5-1 plan | -5,704 | $5.270 | $30 K | 46,100 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Option exercise10b5-1 plan | +11,250 | — | — | 51,804 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +4,573 | — | — | 131,264 | Form 4 |
| filed | Ilan GanotDirector | Sellindirect | -1,053 | $5.430 | $6 K | 17,278 | Form 4 |
| filed | Ilan GanotDirector | Option exerciseindirect | +2,994 | — | — | 18,331 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Sell10b5-1 plan | -4,483 | $5.110 | $23 K | 26,660 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Sell10b5-1 plan | -10,808 | $5.110 | $55 K | 81,388 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Sell10b5-1 plan | -2,701 | $5.110 | $14 K | 26,622 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Sell10b5-1 plan | -4,932 | $5.110 | $25 K | 32,908 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Option exercise10b5-1 plan | +11,862 | — | — | 31,143 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Option exercise10b5-1 plan | +28,612 | — | — | 92,196 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Option exercise10b5-1 plan | +7,239 | — | — | 29,323 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Option exercise10b5-1 plan | +13,051 | — | — | 37,840 | Form 4 |
| filed | Ilan GanotDirector | Sell | -3,278 | $4.120 | $14 K | 95,412 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Sell | -2,895 | $5.960 | $17 K | 33,819 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Option exercise | +9,750 | — | — | 36,714 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +4,573 | — | — | 126,692 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +4,573 | — | — | 122,119 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +4,574 | — | — | 117,546 | Form 4 |
| filed | Clare KahnDirector | Buy | +1,860 | $5.340 | $10 K | 2,960 | Form 4 |
| filed | Joseph EdelmanDirector, 10% owner | Buyindirect | +5.00 M | $4.030 | $20.1 M | 11.83 M | Form 4 |
| filed | BCLS SB Investco, LP10% owner | Buyindirect | +1.00 M | $4.030 | $4.0 M | 5.03 M | Form 4 |
| filed | Robert Atchinson10% owner | Buyindirect | +252,545 | $7.560 | $1.9 M | 4.25 M | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Sell10b5-1 plan | -11,365 | $3.960 | $45 K | 60,717 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Sell10b5-1 plan | -3,256 | $3.960 | $13 K | 22,812 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Sell10b5-1 plan | -3,164 | $3.960 | $13 K | 32,250 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Sell10b5-1 plan | -3,079 | $3.960 | $12 K | 19,281 | Form 4 |
| filed | Ilan GanotDirector | Sell10b5-1 plan · indirect | -1,711 | $3.960 | $7 K | 14,839 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Sell10b5-1 plan | -5,561 | $3.960 | $22 K | 24,789 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Sell10b5-1 plan | -2,688 | $3.960 | $11 K | 18,388 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Option exercise10b5-1 plan | +30,031 | — | — | 72,082 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Option exercise10b5-1 plan | +10,937 | — | — | 26,068 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Option exercise10b5-1 plan | +10,625 | — | — | 35,414 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Option exercise10b5-1 plan | +8,125 | — | — | 22,360 | Form 4 |
| filed | Ilan GanotDirector | Option exercise10b5-1 plan · indirect | +4,861 | — | — | 16,550 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Option exercise10b5-1 plan | +14,687 | — | — | 30,350 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Option exercise10b5-1 plan | +7,187 | — | — | 21,076 | Form 4 |
| filed | Ilan GanotDirector | Sell10b5-1 plan · indirect | -144 | $3.110 | $448 | 11,689 | Form 4 |
| filed | Ilan GanotDirector | Option exercise10b5-1 plan · indirect | +388 | — | — | 11,833 | Form 4 |
| filed | Ilan GanotDirector | Option exercise10b5-1 plan | +3,883 | — | — | 98,690 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Sell | -4,073 | $3.890 | $16 K | 24,789 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Option exercise | +11,250 | — | — | 28,862 | Form 4 |
| filed | Ilan GanotDirector | Sellindirect | -1,056 | $4.310 | $5 K | 11,445 | Form 4 |
| filed | Ilan GanotDirector | Option exerciseindirect | +2,994 | — | — | 12,501 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +3,255 | — | — | 112,972 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Sell | -11,114 | $5.600 | $62 K | 38,484 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Sell | -4,610 | $5.600 | $26 K | 14,235 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Sell | -5,072 | $5.600 | $28 K | 15,663 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Sell | -2,777 | $5.600 | $16 K | 12,182 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Option exercise | +11,862 | — | — | 18,845 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Option exercise | +13,051 | — | — | 20,735 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Option exercise | +28,612 | — | — | 49,598 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Option exercise | +7,239 | — | — | 14,959 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Sell | -2,923 | $6.500 | $19 K | 10,979 | Form 4 |
| filed | Gabriel BrooksChief Medical Officer | Option exercise | +9,750 | — | — | 13,902 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +3,255 | — | — | 109,717 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +3,255 | — | — | 106,462 | Form 4 |
| filed | Clare KahnDirector | Buy | +1,100 | $7.670 | $8 K | 1,100 | Form 4 |
| filed | Ilan GanotDirector | Option exerciseindirect | +1,553 | — | — | 9,969 | Form 4 |
| filed | Ilan GanotDirector | Sellindirect | -462 | $10.33 | $5 K | 9,507 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +3,256 | — | — | 103,207 | Form 4 |
| filed | Ilan GanotDirector | Sellindirect | -139 | $7.990 | $1 K | 8,416 | Form 4 |
| filed | Ilan GanotDirector | Option exerciseindirect | +388 | — | — | 8,555 | Form 4 |
| filed | Ilan GanotDirector | Option exercise | +3,883 | — | — | 94,807 | Form 4 |
| filed | RA Capital Nexus Fund, L.P.Director, 10% owner | Buyindirect | +904,160 | $5.530 | $5.0 M | 4.19 M | Form 4 |
| filed | Adam KoppelDirector, 10% owner | Grant or awardindirect | +904,160 | $5.530 | $5.0 M | 4.03 M | Form 4 |
| filed | BCLS SB Investco, LPDirector, 10% owner | Grant or awardindirect | +904,160 | $5.530 | $5.0 M | 4.03 M | Form 4 |
| filed | Perceptive Xontogeny Venture Fund, LPDirector, 10% owner | Buyindirect | +3.41 M | $5.530 | $18.9 M | 6.83 M | Form 4 |
| filed | Kevin TanCFO & Treasurer | Option exercise | +11,250 | — | — | 13,243 | Form 4 |
| filed | Kevin TanCFO & Treasurer | Sell | -3,935 | $8.200 | $32 K | 9,308 | Form 4 |
| filed | Ilan GanotDirector | Option exerciseindirect | +2,993 | — | — | 9,309 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +15,570 | — | — | 99,948 | Form 4 |
| filed | Ilan GanotDirector | Sellindirect | -1,142 | $5.300 | $6 K | 8,167 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Sell10b5-1 plan | -4,879 | $2.780 | $14 K | 6,983 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Sell10b5-1 plan | -2,968 | $2.770 | $8 K | 4,270 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Sell10b5-1 plan | -11,757 | $2.770 | $33 K | 17,439 | Form 4 |
| filed | Jennifer MarloweCSO | Sell10b5-1 plan | -4,890 | $2.770 | $14 K | 6,998 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Sell10b5-1 plan | -5,367 | $2.780 | $15 K | 7,684 | Form 4 |
| filed | Paul HerzichChief Technology Officer | Option exercise | +7,238 | — | — | 7,238 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Option exercise | +28,612 | — | — | 29,196 | Form 4 |
| filed | Jennifer MarloweCSO | Option exercise | +11,888 | — | — | 11,888 | Form 4 |
| filed | Jessie HanrahanChief Regulatory Officer | Option exercise | +11,862 | — | — | 11,862 | Form 4 |
| filed | Ilan GanotDirector | Option exercise | +1,583 | — | — | 90,924 | Form 4 |
| filed | David T. HowtonChief Operating Officer | Option exercise | +13,051 | — | — | 13,051 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +15,569 | — | — | 84,378 | Form 4 |
| filed | Ilan GanotDirector | Option exercise | +1,583 | — | — | 89,341 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +15,570 | — | — | 68,809 | Form 4 |
| filed | Ilan GanotDirector | Option exercise | +1,583 | — | — | 87,758 | Form 4 |
| filed | Ilan GanotDirector | Option exerciseindirect | +1,553 | — | — | 4,640 | Form 4 |
| filed | Ilan GanotDirector | Sell10b5-1 plan · indirect | -487 | $4.850 | $2 K | 4,153 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +15,569 | — | — | 53,239 | Form 4 |
| filed | Ilan GanotDirector | Option exercise | +1,584 | — | — | 86,175 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Option exercise | +1,233 | — | — | 20,201 | Form 4 |
| filed | Ilan GanotDirector | Option exerciseindirect | +388 | — | — | 1,519 | Form 4 |
| filed | Ilan GanotDirector | Sell10b5-1 plan · indirect | -141 | $7.490 | $1 K | 1,378 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Sell10b5-1 plan | -441 | $7.490 | $3 K | 19,760 | Form 4 |
| filed | Ilan GanotDirector | Option exercise | +3,883 | — | — | 85,973 | Form 4 |
| filed | Ilan GanotDirector | Sell10b5-1 plan | -1,382 | $7.490 | $10 K | 84,591 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +1,620 | — | — | 37,670 | Form 4 |
| filed | Joseph EdelmanDirector, 10% owner | Grant or awardindirect | +2.16 M | $7.050 | $15.2 M | 3.06 M | Form 4 |
| filed | Joseph EdelmanDirector, 10% owner | Grant or awardindirect | +365,536 | — | — | 3.42 M | Form 4 |
| filed | Joseph EdelmanDirector, 10% owner | Grant or awardindirect | +73,107 | — | — | 73,107 | Form 4 |
| filed | Alexander CumboPresident and CEO, Director | Grant or award | +584 | — | — | 584 | Form 4 |
| filed | Ian F. SmithDirector | Grant or award | +13,172 | — | — | 356,380 | Form 4 |
| filed | Ra Capital Management, L.P.Director, 10% owner | Grant or awardindirect | +2.16 M | $7.050 | $15.2 M | 2.99 M | Form 4 |
| filed | Ra Capital Management, L.P.Director, 10% owner | Grant or awardindirect | +300,412 | — | — | 3.29 M | Form 4 |
| filed | Ra Capital Management, L.P.Director, 10% owner | Grant or awardindirect | +109,661 | — | — | 109,661 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +24,312 | — | — | 343,208 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +24,313 | — | — | 318,896 | Form 4 |
| filed | Ian F. SmithDirector | Option exercise | +24,313 | — | — | 294,583 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Operating Officer | Sell10b5-1 plan | -15,232 | $1.100 | $17 K | 251,542 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Sell10b5-1 plan | -11,269 | $1.100 | $12 K | 266,605 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Operating Officer | Sell10b5-1 plan | -15,272 | $1.100 | $17 K | 236,270 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Sell10b5-1 plan | -11,396 | $1.100 | $13 K | 255,209 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Sell10b5-1 plan · indirect | -463 | $1.120 | $519 | 2,518 | Form 4 |
| filed | RA Capital Healthcare Fund LPDirector, 10% owner | Otherindirect | +787,586 | $5.530 | $4.4 M | 787,586 | Form 4 |
| filed | RA Capital Healthcare Fund LPDirector, 10% owner | Otherindirect | +663,720 | $5.530 | $3.7 M | 11.58 M | Form 4 |
| filed | Adam KoppelDirector | Grant or awardindirect | +869,565 | $5.750 | $5.0 M | 7.93 M | Form 4 |
| filed | Joseph EdelmanDirector, 10% owner | Buyindirect | +2.61 M | $5.750 | $15.0 M | 13.41 M | Form 4 |
| filed | Peter KolchinskyDirector, 10% owner | Buyindirect | +2.21 M | $5.750 | $12.7 M | 10.92 M | Form 4 |
| filed | Schneider Joel Solomon ZevChief Operating Officer | Sell10b5-1 plan | -11,699 | $8.840 | $103 K | 280,473 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Sell10b5-1 plan | -11,699 | $8.840 | — | 287,301 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Operating Officer | Sell10b5-1 plan | -11,699 | $8.840 | $103 K | 268,774 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Sell10b5-1 plan | -11,699 | $8.850 | $104 K | 275,602 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Sellindirect | -457 | $7.660 | $4 K | 3,026 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Sell | -10,713 | $6.140 | $66 K | 1.20 M | Form 4 |
| filed | Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy | Sell | -3,473 | $6.140 | $21 K | 335,636 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Technology Officer | Sell | -3,443 | $6.140 | $21 K | 292,172 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Sell | -3,459 | $6.140 | $21 K | 299,000 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Option exercise | +35,500 | — | — | 1.21 M | Form 4 |
| filed | Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy | Option exercise | +11,500 | — | — | 339,109 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Technology Officer | Option exercise | +11,500 | — | — | 295,615 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Option exercise | +11,500 | — | — | 302,459 | Form 4 |
| filed | Joseph Edelman10% owner | Grant or awardindirect | +4.05 M | $3.700 | $15.0 M | 10.80 M | Form 4 |
| filed | Ilan GanotCEO & President, Director | Grant or award | +27,027 | $3.700 | $100 K | 1.18 M | Form 4 |
| filed | Rajeev M. ShahDirector, 10% owner | Grant or awardindirect | +4.94 M | $3.700 | $18.3 M | 8.71 M | Form 4 |
| filed | Matthew Bennett ArnoldDirector | Grant or award | +432,432 | $3.700 | $1.6 M | 3.93 M | Form 4 |
| filed | Ian F. SmithDirector | Grant or award | +270,270 | $3.700 | $1000 K | 270,270 | Form 4 |
| filed | Adam KoppelDirector | Grant or awardindirect | +3.19 M | $3.700 | $11.8 M | 7.06 M | Form 4 |
| filed | Ilan GanotCEO & President, Director | Sellindirect | -299 | $2.440 | $730 | 3,483 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Option exerciseindirect | +800 | — | — | 3,737 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Sell | -11,124 | $2.420 | $27 K | 1.15 M | Form 4 |
| filed | Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy | Sell | -3,591 | $2.420 | $9 K | 327,609 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Technology Officer | Sell | -4,041 | $2.420 | $10 K | 284,115 | Form 4 |
| filed | Lynette HerschaChief Legal Officer | Sell | -5,141 | $2.420 | $12 K | 160,859 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Sell | -3,591 | $2.420 | — | 290,959 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Option exercise | +11,500 | — | — | 294,550 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Option exercise | +35,500 | — | — | 1.16 M | Form 4 |
| filed | Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy | Option exercise | +11,500 | — | — | 331,200 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Technology Officer | Option exercise | +11,500 | — | — | 288,156 | Form 4 |
| filed | Lynette HerschaChief Legal Officer | Option exercise | +16,000 | — | — | 166,000 | Form 4 |
| filed | Lynette HerschaChief Legal Officer | Grant or award | +75,000 | — | — | 150,000 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Technology Officer | Grant or award | +75,000 | — | — | 276,656 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Grant or award | +75,000 | — | — | 283,050 | Form 4 |
| filed | Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy | Grant or award | +75,000 | — | — | 319,700 | Form 4 |
| filed | Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy | Grant or award | +75,000 | — | — | 244,700 | Form 4 |
| filed | Lynette HerschaChief Legal Officer | Grant or award | +75,000 | — | — | 75,000 | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Grant or award | +75,000 | — | — | 208,050 | Form 4 |
| filed | Schneider Joel Solomon ZevChief Technology Officer | Grant or award | +75,000 | — | — | 201,656 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Shares withheld for taxindirect | -293 | $3.150 | $923 | 2,937 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Option exerciseindirect | +800 | — | — | 3,230 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Grant or awardindirect | +2,430 | — | — | 2,430 | Form 4 |
| filed | Adam KoppelDirector | Grant or awardindirect | +1.88 M | $4.650 | $8.7 M | 3.87 M | Form 4 |
| filed | Rajeev M. ShahDirector | Grant or awardindirect | +1.88 M | $4.650 | $8.7 M | 4.57 M | Form 4 |
| filed | Sukumar NagendranDirector | Grant or award | +32,258 | $4.650 | $150 K | 34,258 | Form 4 |
| filed | Martin I. FreedDirector | Grant or award | +53,763 | $4.650 | $250 K | 53,763 | Form 4 |
| filed | Perceptive Advisors LLCDirector, 10% owner | Buyindirect | +2.82 M | $4.650 | $13.1 M | 6.75 M | Form 4 |
| filed | Matthew Bennett ArnoldDirector | Grant or award | +677,419 | $4.650 | $3.1 M | 3.50 M | Form 4 |
| filed | Carl Ashley MorrisChief Scientific Officer | Grant or award | +21,505 | $4.650 | $100 K | 133,050 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Grant or award | +21,505 | $4.650 | $100 K | 1.12 M | Form 4 |
| filed | Matthew Bennett ArnoldDirector | Gift | -562,715 | — | — | 2.82 M | Form 4 |
| filed | Juan Andrey ZarurDirector | Sell10b5-1 plan · indirect | -8,000 | $10.00 | $80 K | 10,189 | Form 4 |
| filed | Boxer Capital, LLC10% owner | Sell | -60,000 | $9.530 | $572 K | 3.47 M | Form 4 |
| filed | Boxer Capital, LLC10% owner | Sell | -115,000 | $9.600 | $1.1 M | 3.53 M | Form 4 |
| filed | Boxer Capital, LLC10% owner | Sell | -275,000 | $10.08 | $2.8 M | 3.65 M | Form 4 |
| filed | Matthew Bennett ArnoldDirector | Sell10b5-1 plan | -1,700 | $31.60 | $54 K | 3.39 M | Form 4 |
| filed | Matthew Bennett ArnoldDirector | Sell10b5-1 plan | -3,300 | $32.20 | $106 K | 3.39 M | Form 4 |
| filed | Matthew Bennett ArnoldDirector | Sell10b5-1 plan | -5,000 | $30.08 | $150 K | 3.39 M | Form 4 |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan · amended | -9,000 | $30.07 | $271 K | 153,746 | Form 4/A |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan | -9,000 | $30.07 | $271 K | 158,046 | Form 4 |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan · amended | -3,007 | $30.20 | $91 K | 168,739 | Form 4/A |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan · amended | -5,693 | $31.44 | $179 K | 163,046 | Form 4/A |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan · amended | -300 | $32.38 | $10 K | 162,746 | Form 4/A |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan | -3,007 | $30.20 | $91 K | 173,039 | Form 4 |
| filed | Jorge Armando QuirozChief Medical Officer | Sell10b5-1 plan | -1,200 | $29.94 | $36 K | 267,042 | Form 4 |
| filed | Jorge Armando QuirozChief Medical Officer | Sell10b5-1 plan | -6,154 | $30.21 | $186 K | 260,888 | Form 4 |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan | -5,693 | $31.44 | $179 K | 167,346 | Form 4 |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan | -300 | $32.38 | $10 K | 167,046 | Form 4 |
| filed | Jorge Armando QuirozChief Medical Officer | Sell10b5-1 plan | -31,426 | $31.41 | $987 K | 229,462 | Form 4 |
| filed | Jorge Armando QuirozChief Medical Officer | Sell10b5-1 plan | -1,370 | $32.24 | $44 K | 228,092 | Form 4 |
| filed | Jorge Armando QuirozChief Medical Officer | Sell10b5-1 plan | -100 | $34.90 | $3 K | 268,242 | Form 4 |
| filed | Juan Andrey ZarurDirector | Sell10b5-1 plan | -100 | $35.00 | $4 K | 691,105 | Form 4 |
| filed | Schneider Joel Solomon ZevSee Remarks | Sell10b5-1 plan · amended | -13,448 | $30.68 | $413 K | 133,198 | Form 4/A |
| filed | Schneider Joel Solomon ZevSee Remarks | Sell10b5-1 plan · amended | -8,542 | $31.10 | $266 K | 124,656 | Form 4/A |
| filed | Ilan GanotCEO & President, Director | Sell10b5-1 plan | -30,900 | $30.70 | $949 K | 1.12 M | Form 4 |
| filed | Schneider Joel Solomon ZevSee Remarks | Sell10b5-1 plan | -13,448 | $30.68 | $413 K | 132,958 | Form 4 |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan | -4,700 | $30.61 | $144 K | 176,046 | Form 4 |
| filed | Schneider Joel Solomon ZevSee Remarks | Sell10b5-1 plan | -8,542 | $31.10 | $266 K | 126,656 | Form 4 |
| filed | Ilan GanotCEO & President, Director | Sell10b5-1 plan | -19,100 | $31.06 | $593 K | 1.10 M | Form 4 |
| filed | Pedro Alvaro AmorrortuChief Operating Officer | Sell10b5-1 plan | -4,300 | $31.08 | $134 K | 171,746 | Form 4 |
| filed | Gilad David Hayeem10% owner | Gift | -35,653 | — | — | 1.95 M | Form 4 |
| filed | Adam KoppelDirector | Buyindirect | +300,000 | $16.00 | $4.8 M | 1.99 M | Form 4 |
| filed | Perceptive Advisors LLCDirector, 10% owner | Buyindirect | +1.00 M | $16.00 | $16.0 M | 3.91 M | Form 4 |
| filed | Rajeev M. ShahDirector | Buyindirect | +1.00 M | $16.00 | — | 2.69 M | Form 4 |
| filed | Perceptive Advisors LLCDirector, 10% owner | Buyindirect | +20,000 | $27.33 | $547 K | 3.93 M | Form 4 |
| filed | Adam KoppelDirector | Option exerciseindirect | +1.69 M | — | — | 1.69 M | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice